Back To: Home : Featured Technology : Flow Cytometry

CLICK HERE FOR WHAT'S NEW IN:
 

Analytica 2020 Show Preview: Aiming for excellence in analysis
February 2020
by Mel J. Yeates  |  Email the author
EDIT CONNECT

SHARING OPTIONS:

Analytica 2020
Messe München Exhibition Center
Munich, Germany
March 31-April 03, 2020
 
Aiming for excellence in analysis
Science meets industry at the biennial Analytica conference
By Mel J. Yeates
 
MUNICH—The very end of March and beginning of April will bring the Analytica conference, held in Munich. A conference organized by Forum Analytik, an alliance of Gesellschaft Deutscher Chemiker (GDCh), Gesellschaft für Biochemie und Molekularbiologie (GBM) and the Deutsche Gesellschaft für Klinische Chemie und Laboratoriumsmedizin (DGKL), Analytica offers a multidisciplinary scientific program that brings users, manufacturers and researchers together and promotes the transfer of knowledge and the exchange of ideas.
 
“There is more than one reason not to miss Analytica 2020—Analytica is the world’s leading trade fair for laboratory technology, analysis and biotechnology,” says Susanne Grödl, exhibition director of Analytica. “The accompanying Analytica conference bridges the gap between research and routine analysis. Analytica presents the entire value chain of the laboratory world—with innovations from analysis and quality control, biotechnology, life sciences and diagnostics —and [has] 1200 exhibitors from all over the world (half from Germany).”
 
The speakers at the Analytica conference are renowned scientists and specialists from all over the world. They report on current topics in analytics, quality control, diagnostics, measurement and testing technology, as well as biotechnology and life sciences. The lectures give an overview of novel methods, procedures, techniques and their application possibilities. Young scientists present the results of their research and innovative applications at the highlight poster show, and attendees are invited to participate in the onsite discussions.
 
“Analytica is the leading stage for current and future innovations. Major market leaders showcase their international and/or European premieres at Analytica in Munich. Test novelties from laboratory technology and visit the practice-oriented supporting program,” adds Grödl. “We offer forums, live labs and ‘explosive’ demonstrations on workplace health and safety, plus exciting presentations at the ‘Personalized Medicine’ theme day and, for startups, at the ‘Finance’ theme days. The special exhibition ‘Digital Transformation’ is unique worldwide—never before has the digital transformation in everyday laboratory practice been portrayed in such a comprehensive and practically oriented manner.”
 
As Grödl tells DDNews, “The megatrends of digitalization and networking are keeping the industry occupied. Hence, we are expanding the Digital Transformation Forum in terms of both space and contents. In addition to keynote speeches, there will be a special show in Hall B2. Industry giants, medium-sized companies and start-ups will be presenting their concepts for the digital transformation live here.”
 
“The Digital Transformation Forum will offer direct know-how transfer with the latest solutions for the world of tomorrow. Participants will attend presentations and discussions with renowned experts on topics, such as: What will the laboratory of the future be like (short, thought-provoking presentations)? Benefits of digital networking (interfaces /LIMS). What does this mean for manufacturers and users? How can I make my laboratory even more efficient? How can laboratory processes be optimized? How can I manage data diversity and, notably, data security? How can regulations and standards be implemented ideally? [And] new developments from the fields of automation and robotics,” she notes.
 
“Walking through the exhibition halls, it is apparent that digitalization has been embraced by all analytical disciplines. The health sector benefits particularly from this. In the areas of image analysis—such as analysis of X-ray images or tissue sections—artificial intelligence is clearly superior to the human brain,” states Grödl. “In the field of oncology, automated pattern recognition enables a more accurate identification of tumors and metastases, and the course of disease can be monitored more effectively.”
 
“Digitalization also allows various diagnostic instruments, such as those for genome and proteome analysis or computed tomography, to be linked and connected with databases. Intelligent software assists physicians with the interpretation. The goal is to understand the pathogenic mechanisms and the modes of action of drugs even better,” she continues. “Future therapies should focus more on the patient’s individual pathology, as this is the only way to increase therapeutic success and reduce side effects. On April 3, Analytica [will devote] a theme day to personalized medicine at the Biotech Forum in Hall A3.
 
“[Analytica] covers the entire spectrum of modern analytics and invites you to look beyond your own specialist boundaries. Those who engage in this will discover synergetic effects. Artificial intelligence technology, for example, not only helps in the evaluation of X-ray images in the medical field, but also in material analysis and quality control. Likewise, DNA analyses can be used not only to recognize diseases or identify people, but also to verify the authenticity of foods.”
 
Grödl tells DDNews that Analytica creates an ideal setting for collaborations between manufacturers and their clients: “Most analytical systems can be used in a variety of ways, but must be adapted to the respective measurement task. Manufacturers modify their devices accordingly and develop specific measurement protocols and data analysis software. They also work closely with users from science and industry to ensure that the systems meet the customer’s specific needs. The unique combination of the world’s leading trade fair, scientific conference and the varied framework program offers suppliers and users from all over the world plenty of opportunity for the exchange of ideas and know-how.”
 
She says that one highlight is an “Action Area” that will demonstrate automated workflow using concrete examples, noting that it will “make the special exhibition globally unique. The centerpiece of the exhibition is a robotic arm demonstrating human-machine collaboration that can be used, among other things, in DNA extraction. Fair visitors can try out process steps for themselves at six hands-on exhibition stands, including sample preparation, intelligent sample logistics, assisted execution of a protocol and optical analysis. Using the example of a networked bioreactor, it becomes clear how digital technologies invariably help to optimize processes. A virtual reality area and the use of a digital laboratory journal provide insight into the laboratory processes of tomorrow and beyond.”
 
Grödl specifies that the Analytica conference has over 200 lectures to bridge the gap between research and routine analysis, and highlights for DDNews readers a series of lectures on March 31 that will focus on biotechnologically produced active pharmaceutical ingredients.
 
“The importance of analysis for the pharmaceutical and healthcare sector pervades the entire Analytica conference. On March 31, sessions on medical informatics and clinical mass spectrometry are on the agenda, and on April  1, the program continues with reference intervals in endocrinology and detection of antibiotic-resistant bacteria and other pathogens,” she continues. “On April 2, liquid biopsies for personalized cancer medicine will move into the focus. This still relatively new technique can be used to detect cancer cells or tumor DNA in the blood.”
 
No other event informs as comprehensively about the entire gamut of chemical and bioanalytical examination methods as the Analytica conference, according to Grödl, who adds, “The multifaceted program … invites you to look beyond your own horizons and let yourself be inspired by colleagues from other analytical disciplines.”
 
Looking at other highlights of the Analytica conference, Grödl notes that during the first two days of the fair, the Biotech Forum in Hall A3 will offer expert lectures on innovative products in the fields of life science and biotechnology, with topics such as next-generation sequencing and the latest practical tips on instrumental analytics.
 
“At the ‘Personalized Medicine’ theme day, experts from biotechnology, pharmaceutical and IT-diagnostic companies, associations and clusters will discuss the current state and future directions of personalized medicine,” she continues. “Why does digitization play such an important role in this area, too? Why does the much-advertised digital medical record only help to a limited extent here, and how can the difficult to calculate costs be covered? On the last day of the fair, from 10 a.m. to 3 p.m., exciting lectures and discussion rounds will highlight the topic from a variety of perspectives and enable everyone to form a comprehensive opinion.”
 
As for what may be in store for next time, “The next [Analytica meeting] will take place in 2022. We currently expect that the topic of digitalization will continue to play a major role in the laboratory, certainly also in conjunction with the topic of sustainability,” concludes Grödl. “Which focus we set [for a meeting] is usually decided one-and-a-half years before the next trade fair. We then pick up on current and future challenges and developments with new concepts and formats, and exhibit these at the fair.”
 

Analytica conference agenda: Sessions and chairs
 
Tuesday, March 31, 2020
Biopharmaceuticals I—From Molecules to Therapy
Dr. Anne Arnold, Immundiagnostik AG, Bensheim
Dr. Roland Kellner, Merck KGaA, Darmstadt
 
Biopharmaceuticals II—From Concepts to Products
Dr. Anne Arnold, Immundiagnostik AG, Bensheim
Dr. Roland Kellner, Merck KGaA, Darmstadt
 
Biopharmaceuticals III—From Candidates to High Quality
Dr. Anne Arnold, Immundiagnostik AG, Bensheim
Dr. Roland Kellner, Merck KGaA, Darmstadt
 
Working Group Medical Informatics—Learning Health System and Laboratory Medicine
Dr. Andreas Bietenbeck, Klinikum rechts der Isar der Technischen Universität München
 
Clinical Mass Spectrometry in Metabolomics Applications
Dr. Christoph Seger, Labormediznisches Zentrum
Dr. Peter Findeisen, MVZ Labor Limbach & Kollegen, Heidelberg
 
Chromatography and Mass Spectrometry: Anything new? I / II / III
Dr. Oliver Schmitz, Universität Duisburg-Essen
 
ABC: Model-based Process Design and Control
Dr. Michael Maiwald, Bundesanstalt für Materialforschung und-prüfung (BAM)
Dr. Günter Gauglitz, Eberhard-Karls Universität Tübingen
 
Innovative Process Analytics
Dr. Tobias Eifert, Covestro Deutschland AG, Uerdingen
 
Trends in Electroanalysis
Dr. Frank-Michael Matysik, Universität Regensburg
 
Biobased and Biomimetic Sensing
Dr. Tilman Sauerwald, Saarland University
 
Targeted and Non-targeted Foodomics Correlated to Bioactivity and Authenticity
Dr. Michael Rychlik, TU München
 
Unraveling Emerging Contaminants in Foods by Modern Analytical Strategies
Dr. Michael Rychlik, TU München
 
Artificial Intelligence and Big Data in Medicine—Quo vadis?
Dr. Mustafa Porsch-Özcürümez, Ruhr-Universität Bochum
 
Wednesday, April 1, 2020
Metabolomics
Dr. Guowang Xu, DICP, Dalian
 
Advanced Microscopy
Dr. Annika Grüneboom, Universitätsklinikum Erlangen
 
Reference Intervals in Endocrinology—Is There a Better Way
Dr. Jürgen Kratzsch, Universitätsklinikum Leipzig
Dr. Martin Bidlingmaier, Klinikum der Universität München
 
Patient Safety and Test Utilization
Dr. Matthias Orth, Vinzenz von Paul Kliniken gGmbH/Marienhospital Stuttgart
Dr. Ralf Lichtinghagen, Medizinische Hochschule Hannover
 
Emerging Topics in Analytical Toxicology, Forensics, and Doping Control I—Isotope Ratio Mass Spectrometry (IRMS) in Analytical Toxicology
Dr. Hans Maurer, Saarland University
 
Emerging Topics in Analytical Toxicology, Forensics, and Doping Control II—Omics and MALDI Applications in Analytical Toxicology
Dr. Hans Maurer, Saarland University
 
Emerging Topics in Analytical Toxicology, Forensics, and Doping Control III—Protein Analysis and Alternative Sampling in Analytical Toxicology
Dr. Hans Maurer, Saarland University
 
New Approaches in the Analysis of Persistent and Mobile Organic Compounds
Dr. Thomas P. Knepper, University of Applied Science Fresenius, Idstein
Dr. Thorsten Reemtsma, Helmholtz-Centre for Environmental Research (UFZ), Leipzig
 
Non-target Screening in Future Water Monitoring
Dr. Torsten C. Schmidt, Universität Duisburg-Essen
Dr. Wolfgang Schulz, Zweckverband Landeswasserversorgung, Stuttgart
 
Analysis of Pathogens and Antibiotic-resistant Bacteria
Dr. Michael Seidel, Technische Universität München
 
ABC: Digital Analytical Sciences
Dr. Ulrich Panne, Bundesanstalt für Materialforschung und-prüfung (BAM)
Dr. Günter Gauglitz, Eberhard-Karls Universität Tübingen
 
ABC: Bioanalytics I—Nanomaterials in BioAnalysis
Dr. Antje Bäumner, Universität Regensburg
 
ABC: Bioanalytics II—Analytics Enabling the Concept of Anywhere Care
Dr. Günter Gauglitz, Eberhard-Karls Universität Tübingen
 
Quality in the Different Phases of Laboratory Medicine
Dr. Alexander von Meyer, Kliniken Nordoberpfalz AG, Weiden
 
Metrology meets Lifescience (working title)
Dr. Gavin O’Conner, Physikalisch-Technische Bundesanstalt (PTB), Braunschweig
 
Thursday, April 2, 2020
New Technologies for OMICS Sample Preparation
Dr. Christian Scherling, Tecan, Kreilsheim
 
Lipidomics
Prof. Markus R. Wenk, Department of Biological Science; National University of Singapore
 
Liquid Profiling to Guide Cancer Therapies
Dr. Christof Winter, Klinikum rechts der Isar der Technischen Universität München
Dr. Georg Erich Hoffmann, Trillium GmbH, Grafrath
 
Current and Future Challenges in Analytical Spectrometry I—Bunsen-Kirchhoff-Award Session
Dr. Kerstin Leopold, Universität Ulm
Dr. Carsten Engelhard, Universität Siegen
 
Current and Future Challenges in Analytical Spectrometry II—Nano- and Single-Particle Techniques in Analytical Spectrometry
Dr. Kerstin Leopold, Universität Ulm
Dr. Carsten Engelhard, Universität Siegen
 
Current and Future Challenges in Analytical Spectrometry III—Laser and Imaging Techniques in Analytical Spectrometry
Dr. Kerstin Leopold, Universität Ulm
Dr. Carsten Engelhard, Universität Siegen
 
High Resolution Mass Spectrometry: Technologies and Applications I—Fourier Transform Cyclotron Resonance Mass Spectrometry (FTICR-MS)
Dr. Ralf Zimmermann, Helmholtz Zentrum München
Dr. Alan G. Marshall, Florida State University
 
High Resolution Mass Spectrometry: Technologies and Applications II—Orbitrap Mass Spectrometry
Dr. Ralf Zimmermann, Helmholtz Zentrum München
Dr. Alexander Makarov, Thermo Fisher Scientific, Bremen
 
High Resolution Mass Spectrometry: Technologies and Applications III—High Resolution Time-of-Flight Mass Spectrometry (HRTOF-MS)
Dr. Ralf Zimmermann, Helmholtz Zentrum München
Dr. Viatcheslav Artaev, LECO Corporation, Michigan
 
Forschungsdatenmanagement I - Innovation for Research Data Management and Mining
Sabine Brunger-Weiland, FIZ Karlsruhe–Leibniz-Institut für Informationsinfrastruktur GmbH
 
Forschungsdatenmanagement II - Data Management Aspects of Human Biobanking
Dr. Michael Kiehntopf, Universitätsklinikum Jena
Dr. Ronny Baber, Universitätsklinikum Leipzig
 
Forschungsdatenmanagement III
Dr. Wolf von Tümpling, Helmholtz-Zentrum für Umweltforschung (UFZ), Magdeburg
 
Pushing the Limits of Separation: Still Much To Discover
Dr. Martin Vogel, Universität Münster
 
Fishing for Protein Biomakers—Cutting-edge immunoassays
Dr. Oliver Poetz, Signatope GmbH, Reutlingen
 

Finance Days
 
Which funding options are available to startups, as well as to small- and medium-sized enterprises? The search for investors often isn't easy for young life-sciences companies. Analytica’s Finance Day, organized by Going Public Media, provides insight into the current challenges and solutions of funding. Company representatives will report on the options they have used on their growth path, and provide practical insights into the issues concerned.
 
Tuesday, March 31, 2020
Start-up Hour
 
Wednesday, April 1, 2020
Finance Day
Panel 1: Venture Capital & Innovationsfinazierung: Aktuelle Trends in der Biotechnologie
Panel 2: Pharma und Biotech: Neue Finanzierungsmodelle für junge Life Science Unternehmen
Panel 3: Börse und Börsengang: IPO—A Piece of a Cake
Panel 4: CHINA—Opportunities and Challenges for Life Science Companies
 
Thursday, April 2, 2020
Focus day—Personalized medicine
 

Analytica Job Day
 
Analytica dedicates an entire day to the topics of jobs and careers. The objective is to bring exhibitors and potential employees together, from technical experts to qualified future professionals. Those interested in a new professional challenge in the fields of analysis, laboratory technology or biotechnology will find the right contacts, and receive valuable tips in lectures, according to conference organizers.
 
jobvector Career Forum
The jobvector Career Forum is an integrated recruiting event at Analytica. Companies from the laboratory technology, analysis and biotechnology sectors will be present onsite as contact partners for job applicants. Both graduates and professionals with job experience will have the opportunity of meeting future employers and informing themselves personally about possible career paths. During the full-day presentation program accompanying the event, the companies exhibiting at the jobvector Career Forum will be presenting individual entry options as well as job profiles and career prospects. At the exclusive Job Wall in Hall B1 (B1.140), applicants can find out about current job offers from top employers.
 
Student Day
All events that are part of the Student Day are available only in German. The Student Day will take place on Friday, April 3, 2020, in the ICM, Room 4. The complete program will be available on Analytica’s website from mid-February.
 

Focus Day: Personalized Medicine
 
Analytica 2020 will again dedicate a day to the topic of personalized medicine. Faster diagnoses and better therapies with personalized active ingredients make a valuable contribution to the successful treatment of patients. As part of the Personalized Medicine Focus day, the latest developments in this field will be analyzed from a variety of perspectives on April 3. Experts from biotech, pharmaceutical and IT diagnostics companies, associations and clusters will discuss the current status and future orientation of personalized medicine.
 

Analytica Awards
 
Bunsen-Kirchhoff Award
The Bunsen-Kirchhoff Award is dedicated mainly to young scientists for extraordinary contributions in the field of spectroscopy. It is awarded by the German Working Group for Analytical Spectroscopy (DAAS) in the GDCh Division Analytical Chemistry. The prize, endowed with €3,000 by Analytik Jena AG, is to be presented at the Analytica conference 2020 on April 2.
 
Eberhard Gerstel Award
The Eberhard Gerstel prize was awarded for the first time in 2010, by the Separation Science working group in the GDCh Division Analytical Chemistry, for an outstanding publication in the field of analytical separation techniques. The biennial prize of €2,000 is donated by GERSTEL GmbH & Co. KG Mülheim an der Ruhr. The Eberhard Gerstel Prize will be awarded as part of Analytica 2020.
 
Application Award and Start Up Award
The newest laboratory equipment or the most sensitive analytical instrument is only one aspect of a successful analysis. Often the right method or application brings the optimal result. To reflect this, LABORPRAXIS is awarding the Application Award again during Analytica 2020. The award looks for the most exciting application in four categories: laboratory technology, biotechnology & pharmaceutical, water & environment, and food analysis. And new in 2020 is the special category “Digital Laboratory.” Applications are open until February 29.
 
 
 
Code: E022036

Back


PAGE UTILITIES


CONTACT US
DDNEWS
1000 N West Street, Suite 1200,
Wilmington, Delaware, 19801
Ph: 888-781-0328 |  Fax: 705-528-0270
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.